Egg Phosphatidylcholine Market worth over $15 Million by 2024
Published Date: April 13, 2017 Author: Global Market Insights, Inc.
Egg Phosphatidylcholine (PC) Market size is poised to exceed USD 15 million by 2024; according to a new research report by Global Market Insights, Inc.
Strong trend towards growth in nutritional food consumption owing to increase in consumer health consciousness should drive egg phosphatidylcholine market size. Egg PC is used to improve digestive system and liver functionality. They are also used for treating various diseases such as memory loss, depressive disorders, tardive dyskinesia, anxiety and Alzheimer.
Positive outlook for nutritional food consumption as a source for protein & choline source in China should drive egg PC market size. USDA has confirmed yolk as an excellent nutrient source and as per National Academy of Science, choline has been included as human vitamins. FDA has imposed ban on injection lipolysis which are used in dissolving fats and strict guidelines set by UK government, which should challenge egg phosphatidylcholine market size.
Egg phosphatidylcholine market size from pharmaceutical applications may generate significant gains at over 5%. Rise in geriatric population has resulted in increase of various old age problems such as Alzheimer’s disease and memory loss, which may stimulate medical supplements demand for health-related disorders treatment.
CVDs which can occur due to yolk owing to unsaturated fatty acids and cholesterol content may limit egg phosphatidylcholine market growth. Vegan consumer base may influence soy market. Additionally, omega-3 ingredients given to livestock by poultry manufacturers should fuel industry growth.
Mustard, soybean, and rapeseed are used by suppliers due to low substitute costs and is preferred in place of egg. This factor may pressurize overall industry profitability and impact egg PC market price trend.
Browse key industry insights spread across 70 pages with 45 market data tables & 12 figures & charts from the report, “Egg Phosphatidylcholine Market Size By Application (Pharmaceutical, Cosmetics, Dietetics), Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, China, Japan), Growth Potential, Price Trend, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents:
Germany egg PC market size from cosmetic applications may generate USD 175 million in business by 2024. Growing health concerns towards personal health and hygiene products among young populations along with shift in focus for natural ingredients in final product formulation should drive regional growth.
U.S. egg phosphatidylcholine market from dietetic applications should witness highest gains at over 4%. Dietetic supplements improve digestion and promote liver function. Growing demand for nutritional foods should drive regional growth.
China egg PC market from pharmaceutical applications should witness significant gains. It is used in curing diseases such as hepatitis, gallbladder, high cholesterol level, eczema, and improvement in dialysis efficiency.
Latin America, driven by Brazil egg phosphatidylcholine market size, should witness significant gains. Growth in cosmetic products demand such as toiletries and fragrances in Brazil should drive regional industry growth. Increasing number of chronic hepatitis problems in LATAM can fuel demand for of liver problem treatment.
Global egg PC market share is consolidated. Key manufacturers are Kewpie Corporation, Lipoid and Nutrasal Other prominent companies include Jena Bioscience, Natural Factors, and NOF America Corporation.
Egg Phosphatidylcholine market research report includes in-depth coverage of the industry, with estimates & forecast in revenue in USD million from 2013 to 2024, for the following segments:
Egg Phosphatidylcholine Market By Application
The above information has been provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East & Africa (MEA)